Dark Forest Capital Management’s 10x Genomics TXG Stock Holding History

Dark Forest Capital Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-26,978	Closed	-$312K	–	1492
2025 Q2	$312K	Sell	26,978 -10,694	-28%	-$97.5K	0.01%	1018
2025 Q1	$329K	Sell	37,672 -48,832	-56%	-$616K	0.01%	1039
2024 Q4	$1.24M	Buy	+86,504	New	+$1.37M	0.18%	115
2023 Q2	–	Sell	-352	Closed	-$19.6K	–	1407
2023 Q1	$19.6K	Buy	+352	New	+$16.4K	﹤0.01%	971
2022 Q2	–	Sell	-37	Closed	-$3K	–	1379
2022 Q1	$3K	Sell	37 -36	-49%	-$3.15K	﹤0.01%	1153
2021 Q4	$11K	Sell	73 -2,123	-97%	-$325K	﹤0.01%	902
2021 Q3	$320K	Buy	+2,196	New	+$377K	0.11%	166

Other funds holding TXG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dark Forest Capital Management's TXG Position: Q3 2025 in Review

Dark Forest Capital Management sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 26,978 shares — an estimated $312K sold.

Dark Forest Capital Management first reported a position in TXG in Q3 2021 and held it in 7 quarters. The position peaked at $1.24M in Q4 2024. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

Dark Forest Capital Management reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
Dark Forest Capital Management sold 26,978 10x Genomics shares in Q3 2025, an estimated $312K.
Dark Forest Capital Management first reported a position in 10x Genomics in Q3 2021 and held it in 7 quarters.
Dark Forest Capital Management's 10x Genomics position peaked at $1.24M in Q4 2024.
317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Dark Forest Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.